Trial Information

Title: Protocol MB102077: A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication

We are conducting a research study to learn if BMS-512148 (Dapagliflozin), after 12 weeks, can improve (decrease) blood pressure in patients with type 2 diabetes with uncontrolled hypertension who are on an Angiotensin-converting enzyme inhibitor (ACEI) or an Angiotensin Receptor Blocker (ARB) and an additional antihypertensive.The safety of this treatment will also be studied. For more information, visit the study’s pages at www.clinicaltrials.gov

Duration: Up to 19 weeks

Compensation: Investigational medication or placebo and study-related care at no cost, as well as compensation for time. Reimbursement for childcare and transportation may be provided.

Patient Inclusion Criteria:
You may be eligible to participate if you:

Are between the ages of 18 and 89
Have Type 2 diabetes and high blood pressure
Are taking an anti-diabetic medication
Are taking blood pressure medication, either: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and are on one additional anti-blood pressure medication
Have inadequately controlled blood sugar levels
Have inadequately controlled high blood pressure

Call 1-877-425-0250 or email crc@kcumb.edu for more information .

Dybedal Clinical Research Center
1750 Independence Ave
Kansas City, MO 64106
Phone: 1-877-425-0250
Fax: 816-654-7651
Email: crc@kcumb.edu

View Map

Research Center Information: Dybedal Clinical Research Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.